24 results found.

Ischemic Dilated Cardiomyopathy (IDCM) Clinical Trial using ixmyelocel-T; Vehicle Control

Aastrom Biosciences - Recruiting 30 years to 86 years.
- MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF TRANSENDOCARDIAL INJECTION OF IXMYELOCEL-T IN SUBJECTS WITH HEART FAILURE DUE TO ISCHEMIC DILATED CARDIOMYOPATHY (IDCM)..
ixmyelocel-T; Vehicle Control

Ventricular Tachycardia, or Cardiomyopathy Clinical Trial using Ablation of ventricular arrhythmias; Ablation of Vts + additional renal denervation

Universit„tsklinikum Hamburg-Eppendorf - Recruiting 18 years or older.
- Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation.
Ablation of ventricular arrhythmias; Ablation of Vts + additional renal denervation

Cardiomyopathy, or Renal Impairment Clinical Trial using Tadalafil; Placebo

Mayo Clinic - Recruiting 21 years to 90 years.
- Define in Preclinical Systolic Dysfunction (PSD) With Renal Dysfunction, the Cardiorenal and Humoral Actions of Chronic Type V Phosphodiesterase (PDEV) Inhibition.
Tadalafil; Placebo

Inflammation, Cancer, or Cardiomyopathy Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage.

Cardiomyopathy Clinical Trial using Ranolazine

Cardiovascular Institute of the South Clinical Research Corporation - Recruiting 18 years to 80 years.
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC).
Ranolazine

Heart Failure, or Dilated Cardiomyopathy Clinical Trial using Algisyl-LVR; Standard medical therapy

LoneStar Heart, Inc. - Recruiting 18 years to 79 years.
- A Randomized, Controlled Study to Evaluate the Safety and Cardiovascular Effects of Algisyl-LVRT as a Method of Left Ventricular Augmentation in Patients With Dilated Cardiomyopathy (AUGMENT-HF).
Algisyl-LVR; Standard medical therapy

Heart Failure, Cardiomyopathy, Dilated, or Coronary Disease Clinical Trial using Resynchronization using a transeptal approach; Resynchronization using a coronary sinus approach

University Hospital, Bordeaux - Recruiting 18 years or older.
- Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure..
Resynchronization using a transeptal approach; Resynchronization using a coronary sinus approach

Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial using Tafamidis; Placebo

Pfizer - Recruiting 18 years to 90 years.
- A Multicenter, International, Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Efficacy, Safety, and Tolerability of Daily Oral Dosing of Tafamidis Meglumine (PF-06291826) 20 mg or 80 mg in Comparison to Placebo in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM).
Tafamidis; Placebo

Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy, Heart Failu Clinical Trial using AAV1/SERCA2a (MYDICAR); Placebo

Celladon Corporation - Recruiting 18 years to 80 years.
- A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICARr (AAV1/SERCA2a) in Subjects With Heart Failure.
AAV1/SERCA2a (MYDICAR); Placebo

Hypertrophic Cardiomyopathy Clinical Trial

French Cardiology Society - Recruiting 15 years or older.
- French Hypertrophic Cardiomyopathy Observatory.

Ischaemic Cardiomyopathy, or Non-ischaemic Cardiomyopathy Clinical Trial

University Hospital Ostrava - Recruiting 18 years to 90 years.
- Heart Rate Variability, Microvolt T-wave Alternans and Cardiac Magnetic Resonance Imaging Analysis in Primary Preventive ImplantablE Cardioverter-defibrillator Recipients Profitability Trial - HAPPIER Trial.

Takotsubo Cardiomyopathy Clinical Trial using ------

University of Zurich - Recruiting 18 years or older.
- International Multicenter Registry on Takotsubo Cardiomyopathy.
------

Heart Failure, Vitamin D Deficiency, Cardiomyopathy, or Congestiv Clinical Trial using Placebo Comparator: Sugar Pill; Vitamin D3 (cholecalciferol)

Saint Patrick Hospital - Recruiting N/A or older.
- Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients.
Placebo Comparator: Sugar Pill; Vitamin D3 (cholecalciferol)

Cardiomyopathy Clinical Trial

North Shore Long Island Jewish Health System - Recruiting 18 years or older.
- Understanding the Molecular Basis of Ventricular Arrhythmias in Uremic Cardiomyopathy.

Dilated Cardiomyopathy, or Chronic Heart Failure Clinical Trial using Intramyocardial injection; Intracoronary injection

University Medical Centre Ljubljana - Recruiting 18 years to 65 years.
- Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy.
Intramyocardial injection; Intracoronary injection

Hypertrophic Cardiomyopathy Clinical Trial using Trimetazidine; Placebo capsule

University College, London - Recruiting 18 years or older.
- A Phase 2b Randomised, Double Blind, Placebo-controlled Trial of Trimetazidine Therapy in Patients With Non-obstructive Hypertrophic Cardiomyopathy.
Trimetazidine; Placebo capsule

Cardiomyopathy, or Heart Failure Clinical Trial using POMx, pomegranate polyphenol extract; Sugar Pill

University of Michigan - Recruiting 21 years or older.
- The Impact of Pomegranate (Punica Granatum) Polyphenol Extract on Oxidative Stress, Ventricular Remodeling and Endothelial Function in Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study.
POMx, pomegranate polyphenol extract; Sugar Pill

Heart Disease Clinical Trial using Intramyocardial Cell therapy

Asklepios proresearch - Recruiting 18 years to 80 years.
- Protocol on an Evaluative Study on Bone Marrow Derived Mononuclear Cells for Optimization of Biventricular Pacing in Patients With Chronic Ischemic Left Ventricular Dysfunction.
Intramyocardial Cell therapy

Heart Failure Clinical Trial using autologous CD133pos stem cell application

Asklepios proresearch - Recruiting 18 years to 80 years.
- Pilot Study Comparing the Effect of Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells for Improving Left Ventricular Function in Chronic Ischemic Cardiomyopathy.
autologous CD133pos stem cell application

Tako-TSUBO Cardiomyopathy, or Acute Coronary Syndrome Clinical Trial

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Genetic Polymorphisms in Catecholamine Pathway Responsible for the Tako-TSUBO Cardiomyopathy Susceptibly (TAKO-GENE).

Cardiomyopathy, Dilated Clinical Trial using Observational study, no intervention

University Health Network, Toronto - Recruiting 18 years to 80 years.
- .
Observational study, no intervention

Ischemic Cardiopathy Clinical Trial using Mini-thoracotomy for intramyocardial injection of VEGF165

Instituto de Cardiologia do Rio Grande do Sul - Recruiting N/A to 75 years.
- Induced Angiogenesis by Genic Therapy With VEGF165 in Advanced Ischemic Cardiomyopathy - Historical Controlled Trial.
Mini-thoracotomy for intramyocardial injection of VEGF165

Systolic Heart Failure, Myocardial Disease, or Cardiomyopathy Clinical Trial using Verapamil

Medical University of Silesia - Recruiting 18 years to 65 years.
- Prospective, Randomized Comparison of Therapy With Verapamil or Carvedilol on Long-Term Outcomes of Patients With Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy.
Verapamil

Congestive Heart Failure, Ischemic Cardiomyopathy, Coronary Arter Clinical Trial using Blue Egg Device

BioVentrix - Recruiting 18 years or older.
- A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart.
Blue Egg Device